middle.news
How Argent BioPharma Is Transforming Epilepsy Treatment Across Europe
3:32pm on Thursday 31st of July, 2025 AEST
•
Healthcare
Read Story
How Argent BioPharma Is Transforming Epilepsy Treatment Across Europe
3:32pm on Thursday 31st of July, 2025 AEST
Key Points
Formal supply of cannabinoid API to University Medical Centre Ljubljana
CannEpil™ approved for prescription in Germany under special access scheme
Strategic manufacturing agreements secured in Malta and Slovenia
Quarterly operating outflows of A$2.29 million with strong financing inflows
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Argent Biopharma (ASX:RGT)
OPEN ARTICLE